Siyan Li - Search Results

Year	Number of Results
2010	1
2014	1
2015	2
2016	2
2017	1
2019	1
2020	4
2021	8
2022	8
2023	9
2024	6

1

The Role of Progesterone Receptors in Breast Cancer.

Li Z, Wei H, Li S, Wu P, Mao X. Li Z, et al. Among authors: li s. Drug Des Devel Ther. 2022 Jan 26;16:305-314. doi: 10.2147/DDDT.S336643. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35115765 Free PMC article. Review.

2

Advances in inhibitors of potential tumor target FOXM1.

Han XY, Zhou ZY, Li SY, Xue ST. Han XY, et al. Future Med Chem. 2023 May;15(10):809-812. doi: 10.4155/fmc-2023-0118. Epub 2023 May 25. Future Med Chem. 2023. PMID: 37226453 Free article. No abstract available.

3

Osteoporosis: Emerging targets on the classical signaling pathways of bone formation.

Li SY, Xue ST, Li ZR. Li SY, et al. Eur J Pharmacol. 2024 Jun 15;973:176574. doi: 10.1016/j.ejphar.2024.176574. Epub 2024 Apr 19. Eur J Pharmacol. 2024. PMID: 38642670 Review.

4

Paeonol attenuates inflammation by confining HMGB1 to the nucleus.

Miao J, Zhong J, Lan J, Ye S, Ye P, Li S, You A, Chen X, Liu X, Li H. Miao J, et al. Among authors: li s. J Cell Mol Med. 2021 Mar;25(6):2885-2899. doi: 10.1111/jcmm.16319. Epub 2021 Feb 3. J Cell Mol Med. 2021. PMID: 33534963 Free PMC article.

5

Study on preparation of a Streptococcus suis ghost vaccine.

Li S, Wang D, Guo C, Tian M, Liu Q, Pan Z. Li S, et al. Microb Pathog. 2021 May;154:104865. doi: 10.1016/j.micpath.2021.104865. Epub 2021 Mar 24. Microb Pathog. 2021. PMID: 33771628

6

Integration of network pharmacology with experimental validation to reveal the mechanism of action of Longdan Xiegan Decoction against HSV2 infection and determine its effective components.

Li Y, Li S, Shou Z, Li Y, Li A, Liu W, Zhang X, Zhou C, Xu D, Li L. Li Y, et al. Among authors: li s. J Ethnopharmacol. 2024 May 10;325:117861. doi: 10.1016/j.jep.2024.117861. Epub 2024 Feb 3. J Ethnopharmacol. 2024. PMID: 38316223

7

Paeonol inhibits melanoma growth by targeting PD1 through upregulation of miR-139-5p.

Chen X, Xu Z, Lu M, Ding W, Zhong J, Deng S, Li S, Miao J, Liu X, Wen Q, Ye S, Li C, Li H. Chen X, et al. Among authors: li s. Biochem Biophys Res Commun. 2023 May 14;656:86-96. doi: 10.1016/j.bbrc.2023.03.005. Epub 2023 Mar 5. Biochem Biophys Res Commun. 2023. PMID: 36958259 Free article.

8

Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer.

Zhou ZY, Han XY, Sun LQ, Li SY, Xue ST, Li ZR. Zhou ZY, et al. Front Chem. 2022 Nov 24;10:1058256. doi: 10.3389/fchem.2022.1058256. eCollection 2022. Front Chem. 2022. PMID: 36505747 Free PMC article.

9

UVEAL EFFUSION ASSOCIATED WITH LOCALIZED SCLERODERMA BECAUSE OF SCLERAL FIBROSIS.

Li S, Liu W, Zhao M, Li Y, Li X, Shi X. Li S, et al. Retin Cases Brief Rep. 2023 Jul 1;17(4):406-409. doi: 10.1097/ICB.0000000000001206. Retin Cases Brief Rep. 2023. PMID: 37364200

10

A011, a novel small-molecule ligand of σ₂ receptor, potently suppresses breast cancer progression via endoplasmic reticulum stress and autophagy.

Li Y, Xie X, Liao S, Zeng Z, Li S, Xie B, Huang Q, Zhou H, Zhou C, Lin J, Huang Y, Xu D. Li Y, et al. Among authors: li s. Biomed Pharmacother. 2022 Aug;152:113232. doi: 10.1016/j.biopha.2022.113232. Epub 2022 Jun 6. Biomed Pharmacother. 2022. PMID: 35679718 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year